MicroMGx (Accelerator)

Funding Details
Awarder
PlugAndPlayTechCenter
Date Award
May 15, 2024
Funding URL
View Funding Page

Company Info
Company Description
Our patented natural herbicide will help global farmers defeat herbicide resistant weeds – the 1st new MoA in 35 years. MicroMGx is a Delaware C Corp, based in Chicago, and owns the exclusive rights to this herbicide -mgx 1001. The yield loss due to resistant weeds could feed 1 billion people and the problem is getting worse. Herbicide resistance is the culprit but resistance can be fought with new mechanisms of action. In the last 35 years, noone has marketed a broad spectrum herbicide with a new mechanism - so weeds have evolved to resist one herbicide after the other. Farmers need help. Our lab and greenhouse testing show good activity on broadleaf weeds and against RoundUp resistant weeds. After more testing,we will enter early development with the right licensee. This $34B global herbicide mkt needs a product to defeat herbicide resistance. Our licensing plan is to receive an upfront payment of $30M, milestone payments over 6 years totaling $150M, and royalties of 5%-10%. Our expert team includes our chairman, Prof Bill Metcalf from UIUC who discovered this herbicide. Our CSO is Dr. Anthony Goering and is an expert in genomics, metabolomics, and bioinformatics. Our CEO, Jack Kloeber, PhD, was a leader (LTC) in the Army, then moved to Pharma and Ag R&D decision making.

Links
Back to Home View Funding Announcement